BioCentury | Nov 7, 2018
Translation in Brief

Expanding the reach of plant exosomes

...cancer patients. Another trial, led by author Donald Miller, is using plant exosomes to deliver curcumin...
BioCentury | Mar 3, 2016
Distillery Therapeutics

Therapeutics: Thioredoxin reductase

...cell line. Chemical synthesis and testing in a human lung cancer cell-based assay of hybrid ligustrazine-curcumin...
BioCentury | Oct 5, 2015
Tools & Techniques

J&J intercepts Nextera

...that targets dendritic cells to induce T cell tolerance. The liposome encapsulates the NF-kB inhibitor curcumin...
BioCentury | Mar 2, 2015
Product Development

Prevention by the pound

...that targets dendritic cells to induce T cell tolerance. The liposome encapsulates the NF-kB inhibitor curcumin...
BioCentury | Sep 25, 2013
Financial News

K94 raises $300,000 in seed financing

...Capital. The company is developing targeted drug conjugates that combine luteinizing hormone-releasing hormone (LHRH) with curcumin...
BioCentury | Jun 24, 2013
Clinical News

Retinal test for Alzheimer's disease: Pilot trial ongoing

...Australian Imaging, Biomarker & Lifestyle (AIBL) Flagship Study. NeuroVision said individuals will be given a curcumin...
...identify the predictive value of biomarkers, cognitive variables and lifestyle factors for progression to AD. Curcumin...
...disease Business: Diagnostic Molecular target: NA Description: Test that uses retinal image fluorescence photography and curcumin...
BioCentury | Sep 27, 2012
Tools & Techniques

Slipping therapeutics to the mitochondria

...AD, curcumin-loaded, targeting nanoparticles increased cell viability compared with empty targeting nanoparticles or curcumin alone. Curcumin...
...Marrache next plan to use their nanoparticle system in vivo . "We will first test curcumin...
BioCentury | May 21, 2012
Clinical News

Curcumin: Phase I/II started

...Research Experimental Cancer Medicine Center began an open-label, U.K Phase I/II trial to evaluate once-daily curcumin...
...doses of curcumin plus FOLFOX in about 9 patients. The Phase II portion will compare curcumin...
...FOLFOX vs. FOLFOX alone in about 33 patients. Cancer Research UK , London, U.K. Product: Curcumin...
BioCentury | Nov 19, 2009
Distillery Techniques

Technology: Imaging

...Publication and contact information Imaging Near-infrared imaging of b-amyloid (Ab) deposits with curcumin-derived compounds A curcumin-derived...
...binding to aggregates in vitro and in brain slices from AD mouse models, the fluorescent curcumin...
BioCentury | Jun 25, 2009
Strategy

Science for export

...Corp. Quantum dots for optoelectronic, security and life-science applications 2003 Pittsburgh, Pa. $100K Curry Pharmaceuticals Curcumin-based...
Items per page:
1 - 10 of 18